Wolters Kluwer Sells French Healthcare Publishing Activities to GalilÃ©e
Alphen aan den Rijn (September 30, 2013) - Wolters Kluwer today announced that
it has completed the disposal of its French healthcare publishing activities to
This divestiture is part of the broader Pharma divestment program originally
announced in July 2011. Since that time, the pharma-related assets, including
the activities sold today, have been treated as assets held for sale and have
been included in discontinued operations.
The French assets included in today's disposal were part of the Legal &
Regulatory portfolio and encompass healthcare magazines and journals for
pharmacists, veterinarians, dentists, nurses and physicians, as well as related
trade show and training activities. NewsMed - a company held by GalilÃ©e - will
take on the healthcare publishing activities located in France, and GalilÃ©e
takes on directly activities in the United Kingdom.
The divestment will enable Wolters Kluwer Legal & Regulatory to focus on its
core legal and compliance information and software offerings.
Terms of the deal were not disclosed.
About Wolters Kluwer
Wolters Kluwer is a leading global information services and solutions company.
It provides information, software, and services that help legal, tax, finance,
and healthcare professionals make their most critical decisions effectively and
with confidence. Customers depend on Wolters Kluwer services and solutions to
successfully move through the complex layers of data and regulation that define
modern business and government.
Wolters Kluwer had 2012 annual revenues of â‚¬3.6 billion. The Group employs over
19,000 people worldwide and maintains operations in over 40 counties across
Europe, North America, Asia Pacific, and Latin America. The Company is
headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are
included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored
Level 1 American Depositary Receipt program. The ADRs are traded on the over-
the-counter market in the U.S. (WTKWY).
Visit our website, YouTube, follow @Wolters_Kluwer on Twitter, or look up
Wolters Kluwer on Facebook for more information about our customers, market
positions, brand, and organization.
This press release contains forward-looking statements. These statements may be
identified by words such as "expect", "should", "could", "shall" and similar
expressions. Wolters Kluwer cautions that such forward-looking statements are
qualified by certain risks and uncertainties that could cause actual results and
events to differ materially from what is contemplated by the forward-looking
statements. Factors which could cause actual results to differ from these
forward-looking statements may include, without limitation, general economic
conditions; conditions in the markets in which Wolters Kluwer is engaged;
behavior of customers, suppliers, and competitors; technological developments;
the implementation and execution of new ICT systems or outsourcing; and legal,
tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as
risks related to mergers, acquisitions, and divestments. In addition, financial
risks such as currency movements, interest rate fluctuations, liquidity and
credit risks could influence future results. The foregoing list of factors
should not be construed as exhaustive. Wolters Kluwer disclaims any intention or
obligation to publicly update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise.
Caroline Wouters Meg Geldens
t +31 172 641 470 t + 31 172 641 407
PDF version of Press Release:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Wolters Kluwer NV via Thomson Reuters ONE